Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
Minitran 5 mg/24 h, transdermal patch.
| Pharmaceutical Form |
|---|
|
Adhesive transdermal patch. |
Minitran 5 has a surface area of 6.7 sq cm and contains 18 mg of glyceryl trinitrate. The average amount delivered in 24 hours is 5 mg.
For the full list of excipients, see section 6.1
| Active Ingredient | Description | |
|---|---|---|
| Glyceryl trinitrate |
Glyceryl trinitrate is a vasodilator and is used for angina of effort. Vasodilation is achieved by the releasing of free redical nitric oxide which activates guanylate cyclase and increases synthesis of guanosine 3′ and 5′-monophosphate with resultant effects on the phosphorylation of proteins in smooth muscle. If taken in excess, its vasodilatory effect can cause headache. |
| List of Excipients |
|---|
|
Isooctyl acrylate/Acrylamide copolymer (93:7) |
Each patch is individually packed in a heat sealed foil sachet. Cartons contain 30 patches.
Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
PL 46302/0177
28 February 1999 / 7 December 2005
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
